CUTIA-B(02487)

5.900-0.500-7.81%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

Company Profile
Company Name
CUTIA-B
Market
SEHK
Establishment Date
- -
Employees
- -
Office Location
- -
Website
http://www.cutiatx.com
Zip Code
- -
Phone
- -
Fax
- -
Introduction
Cutia Therapeutics is a China-based company mainly engaged in the research and development and manufacture of dermatological biological drugs. The Company is committed to developing comprehensive solutions to meet the diverse needs of patients and consumers in a wide range of dermatological treatment and care markets. The Company is mainly engaged in clinical trials of its core product CU-20401. This product is mainly used to treat submental fat accumulation. The Company conducts its businesses in the domestic market and overseas markets.

1D
5D
Day
Week
Month

High

6.400

Open

6.400

Volume%

1.24

Low

5.820

Close

6.400

T/O Rate

0.94%

抱歉，当前请求异常(-1)

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"pagemeta":{"title":"CUTIA-B(02487),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CUTIA-B(02487) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CUTIA-B,02487,CUTIA-B股票,CUTIA-B股票老虎,CUTIA-B股票老虎国际,CUTIA-B行情,CUTIA-B股票行情,CUTIA-B股价,CUTIA-B股市,CUTIA-B股票价格,CUTIA-B股票交易,CUTIA-B股票购买,CUTIA-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CUTIA-B(02487),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CUTIA-B(02487) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"summary","symbol":"02487","data":{"stockData":{"symbol":"02487","market":"HK","secType":"STK","nameCN":"CUTIA-B","latestPrice":5.9,"timestamp":1742544503031,"preClose":6.4,"halted":0,"volume":2996600,"delay":0,"floatShares":319000000,"shares":319000000,"eps":-10.280709934145563,"marketStatus":"Market Closed","change":-0.5,"latestTime":"03-21 16:08:23","open":6.4,"high":6.4,"low":5.82,"amount":18042288,"amplitude":0.090625,"askPrice":5.9,"askSize":17600,"bidPrice":5.84,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-1.8403589375821237,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1742779800000},"marketStatusCode":7,"adr":0,"listingDate":1686499200000,"exchange":"SEHK","adjPreClose":6.4,"openAndCloseTimeList":[[1742520600000,1742529600000],[1742533200000,1742544000000]],"volumeRatio":1.237538303909068,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":null,"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://www.cutiatx.com","stockEarnings":[{"period":"1week","weight":0.0536},{"period":"1month","weight":0.1049},{"period":"3month","weight":-0.1362},{"period":"6month","weight":-0.5959},{"period":"1year","weight":-0.29},{"period":"ytd","weight":-0.1667}],"compareEarnings":[{"period":"1week","weight":-0.0113},{"period":"1month","weight":0.0325},{"period":"3month","weight":0.2013},{"period":"6month","weight":0.2975},{"period":"1year","weight":0.4048},{"period":"ytd","weight":0.1809}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Cutia Therapeutics is a China-based company mainly engaged in the research and development and manufacture of dermatological biological drugs. The Company is committed to developing comprehensive solutions to meet the diverse needs of patients and consumers in a wide range of dermatological treatment and care markets. The Company is mainly engaged in clinical trials of its core product CU-20401. This product is mainly used to treat submental fat accumulation. The Company conducts its businesses in the domestic market and overseas markets.","exchange":"SEHK","name":"CUTIA-B","nameEN":"CUTIA-B"},"aProfile":null}}}